Summary
This 8-K filing by McKesson Corporation (MCK) announces a significant change in executive leadership. Marc E. Owen has resigned from his role as Executive Vice President, Corporate Strategy and Business Development, effective March 31, 2012. This departure is notable as Mr. Owen was previously identified as a "named executive officer" in the company's 2011 proxy statement, indicating his prior senior-level involvement. While stepping down from his corporate strategy role, Mr. Owen will continue his involvement with McKesson by serving as the President of McKesson Specialty Health, a position he assumed in January 2012. Investors should view this as a transition rather than a complete exit from the company, with his focus shifting to a specific business unit. The filing details this organizational change, and the company's legal counsel signed off on the report, ensuring proper disclosure.
Key Highlights
- 1Marc E. Owen resigned as Executive Vice President, Corporate Strategy and Business Development, effective March 31, 2012.
- 2Mr. Owen was a 'named executive officer' in the company's 2011 proxy statement.
- 3Despite resignation from his corporate role, Mr. Owen will continue as President of McKesson Specialty Health.
- 4His role as President of McKesson Specialty Health began on January 31, 2012.
- 5The filing is a Form 8-K, indicating a material event for the company.
- 6The report was filed on April 4, 2012, with an event date of March 31, 2012.